King’s Speech

Lord Patel Excerpts

Tuesday 14th November 2023 Lords Chamber

[Lord Patel (CB)]

My Lords, I am pleased to take part in this debate on the gracious Speech and look forward to the three maiden speeches. I will speak briefly about the Government’s policy for science, innovation and technology, the regulation of AI and the use of data for research.

I fully acknowledge the clear commitment of this Government to science, technology and innovation, demonstrated by creating a Department for Science, Innovation and Technology, as already mentioned, maintaining UK membership of Horizon Europe, committing to public funding of R&D of £20 billion by 2024-25, passing the Genetic Technology (Precision Breeding) Act and creating the AI Safety Institute—all good news.

However, I was disappointed that the gracious Speech did not include the land use framework promised by Defra, the recommendations of the Skidmore review for an evidenced-based net-zero technology road map, nor regulation of genetically modified crops or the reform of narrow A-levels in education.

The science community also needs commitment to long-term funding at least 10 years ahead, as opposed to short-term, stop-start investment in science, as already mentioned by the noble Baroness, Lady Jones of Whitchurch. The UK is not alone in seeking to grow its R&D capabilities, with some countries significantly increasing their R&D funding to 3% to 3.7% of their GDP. For the UK to succeed, we also need to be open to the rest of the world.

The punitive cost of visas and health charges, as already mentioned by the noble Lord, Lord Clement-Jones, undermines our ability to attract talented individuals and we are losing out to our competitors. The Government need to address the issue of visa fees for young scientists.

To become a genuine science superpower, the Government need to go further than they have. A brilliant paper titled Wired for Success, produced by Onward, identifies four key principles as a guide to reforms to make the UK a science superpower. Setting an ambitious target for R&D spend, creating a future centre for technology and exempting the Department for Science from Treasury controls are some of its key messages. The noble Lord, Lord Willetts, who played a key part in the report, may well say more.

Universities are key players in science-based activity, but some are finding it difficult to fund the infrastructure required to do so. As argued by CRUK, quality-related funding, or QR funding, and the charity research support fund, the CRSF, are two critical forms of government support for universities. But QR has eroded in the last decade and CRSF has declined in value as charities’ funding for research has increased. I hope the Minister will indicate what plans the Government have to increase QR and CRSF funding to universities.

As universities are major players in not only discovery science but innovation, is it not appropriate for the Department for Science, Innovation and Technology to be the home department for universities, instead of the Department for Education?

As for the regulation of AI, in my view, the broad principles on which AI regulations should be framed, apart from safety, should include the broader societal context, as was well articulated by the right reverend Prelate the Bishop of Oxford in his speech yesterday. We need a bottom-up approach that captures a range of uses. Regulation should identify where responsibility lies and there should be clarity around transparency, accountability and redress. Finally, we need a global angle with regulations that work across nations.

I turn to the use of data for research. The world is on the cusp of a data revolution in biomedical research. Large-scale linkages and analyses of health data will drive innovations in health and care design and delivery. The 1.3 million daily contacts with the NHS generate data on health and well-being, diagnostics, imaging and genomic data at immense scale. The use of this data in a secure and co-ordinated way can optimise health care, manage the health service, augment clinical trials, improve population health management and, importantly, drive research and development. HDR UK—that is, Health Data Research UK—and others are already making progress in vaccine uptake, generative AI for retinal scans and many other areas in health.

The transformative potential of health data research in the UK is far from being realised, with significant gaps in the use of primary care data. A number of challenges remain in order to realise the benefits of health data research at scale. These challenges include demonstrating trustworthiness, creating a data ecosystem, streamlining data access, addressing skills needs, addressing issues on attitudes to risk aversion and protectionism and securing clear specific guidance from the Information Commissioner’s Office. Without access to health data for research, the Government’s life sciences strategy could fail.

The law is part of the problem—the Data Protection and Digital Information (No. 2) Bill will not have a significant impact on health data science unless it is amended. I hope the Government recognise the importance of the use of health data for research and intend to do something about it through legislation. I look forward to the Minister’s comments.

In conclusion, the Government have shown commitment to the UK being a science superpower, but to achieve this they will need to do more, with the Department of Science, Innovation and Technology having a central role with clear delivery plans. They need to engage more widely with the science and technology community. It would be good if the Minister could reaffirm the independence of research funding bodies, including UKRI.